Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Income from Continuing Operations (2022 - 2025)

Envoy Medical's Income from Continuing Operations history spans 4 years, with the latest figure at 6179000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 17.96% year-over-year to 6179000.0; the TTM value through Sep 2025 reached 22408000.0, up 14.69%, while the annual FY2024 figure was 20072000.0, 9.26% down from the prior year.
  • Income from Continuing Operations for Q3 2025 was 6179000.0 at Envoy Medical, down from 5694000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 12461381.0 in Q1 2022 and bottomed at 11116404.0 in Q4 2023.
  • The 4-year median for Income from Continuing Operations is 4920000.0 (2024), against an average of 2216415.87.
  • The largest YoY upside for Income from Continuing Operations was 55.62% in 2024 against a maximum downside of 785.52% in 2024.
  • A 4-year view of Income from Continuing Operations shows it stood at 2008739.0 in 2022, then crashed by 453.4% to 11116404.0 in 2023, then skyrocketed by 55.62% to 4933000.0 in 2024, then decreased by 25.26% to 6179000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Income from Continuing Operations are 6179000.0 (Q3 2025), 5694000.0 (Q2 2025), and 5602000.0 (Q1 2025).